KI, OUH, Research unit of OPEN - Open Patient data Explorative Network (Odense)

Medicine & Life Sciences

1. Denmark 100%
2. Cohort Studies 84%
3. Guinea-Bissau 74%
4. Randomized Controlled Trials 60%
5. Vaccination 58%
6. Child 50%
7. Population 46%
8. Mortality 44%
9. Systematic Reviews 37%
10. Registries 36%
11. Osteoporosis 36%
12. Twins 33%
13. Confidence Intervals 32%
14. Vaccines 31%
15. Measles Vaccine 31%
16. Therapeutics 28%
17. Health 28%
18. Parturition 27%
19. Quality of Life 25%
20. Diphosphonates 25%
21. Hip Fractures 24%
22. Prospective Studies 23%
23. Pregnancy 23%
24. Bone and Bones 23%
25. Meta-Analysis 23%
26. Mothers 23%
27. Twin Studies 23%
28. Delivery of Health Care 22%
29. Bone Density 22%
30. Poliomyelitis 22%
31. Bacillus 22%
32. Measles 21%
33. Cross-Sectional Studies 20%
34. Osteoporotic Fractures 19%
35. Incidence 19%
36. Type 2 Diabetes Mellitus 19%
37. Comorbidity 18%
38. BCG Vaccine 18%
39. Diabetic Retinopathy 17%
40. Observational Studies 17%
41. Placebos 17%
42. Odds Ratio 17%
43. Vitamin A 17%
44. Bone Remodeling 16%
45. Mycobacterium bovis 16%
46. Survival 16%
47. Neoplasms 16%
48. Type 1 Diabetes Mellitus 15%
49. Biomarkers 15%
50. Patient Reported Outcome Measures 15%
51. Vitamin D 15%
52. Prescriptions 14%
53. Exercise 14%
54. Serum 14%
55. Haemophilus influenzae type b 14%
56. Morbidity 13%
57. Whooping Cough 13%
58. Immunity 13%
59. Lung Neoplasms 13%
60. Diphtheria 13%
61. Child Mortality 13%
62. Rheumatoid Arthritis 13%
63. Databases 12%
64. Tetanus 12%
65. Alendronate 12%
66. Alcoholism 12%
67. Mental Health 12%
68. Pain 12%
69. Alcohols 12%
70. Infections 12%
71. Heterologous Immunity 11%
72. Income 11%
73. Pandemics 11%
74. Safety 11%
75. Infant Mortality 11%
76. Norway 11%
77. Polycystic Ovary Syndrome 11%
78. Interviews 11%
79. Diphtheria-Tetanus-Pertussis Vaccine 11%
80. Body Mass Index 10%
81. Referral and Consultation 10%
82. Guidelines 10%
83. Cardiovascular Diseases 10%
84. Outpatients 10%
85. Smoking 10%
86. Pharmaceutical Preparations 9%
87. Depression 9%
88. Pregnant Women 9%
89. Dizygotic Twins 9%
90. Breast Neoplasms 9%
91. Cytokines 9%
92. Uterine Cervical Neoplasms 9%
93. Asthma 9%
94. Coronavirus 9%
95. Genes 9%
96. Demography 9%
97. Logistic Models 9%
98. Multicenter Studies 9%
99. Hospitalization 9%
100. Sweden 9%